BNTC vs LLY · $388.7M cap vs P/E 39, rev $22.97B
Benitec Biopharma Ltd ADR (BNTC) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Benitec Biopharma Ltd ADR (BNTC) is a biotechnology company listed on NASDAQ.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported BNTC revenue for 2026-03-31 was $0. Net income was -$32.7M. BNTC currently screens at market cap $388.7M.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
BNTC currently screens at market cap $388.7M. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the BNTC and LLY stock pages for the full models.
Not investment advice.